Innoveren Scientific Inc. (OTCPK: IVRN)
Health Care · Biotechnology · US
$—
— today · — 1Y
Innoveren Scientific Inc. (OTCPK: IVRN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.20K and employs 2 people.
trading between 0.00 and 0.00.
Tweenvest scores Innoveren Scientific Inc. across four factors: quality 12/100, value 33/100. Its strongest factor is value.
IVRN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.20K
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- -5.51
- Dividend yield
- —
- Beta (5Y)
- 467.38
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.01M
- Employees
- 2
- Next earnings
- —
About Innoveren Scientific Inc.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
- ISIN
- US4041243076
- Listed since
- Dec 19, 2014
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MultiCell Technologies, Inc.OTCPK: MCET | $5.00K | $0.00 | — |
| Arno Therapeutics, Inc.OTCPK: ARNI | $4.98K | $— | — |
| Affimed N.V.OTCPK: AFMD.Q | $4.92K | $0.00 | +50.00% |
| Todos Medical Ltd.OTCPK: TOMD.F | $3.32K | $0.00 | — |
| Comera Life Sciences Holdings, Inc.OTCPK: CMRA | $3.07K | $0.00 | — |
| Anthera Pharmaceuticals, Inc.OTCPK: ANTH | $2.62K | $0.00 | — |
| TetraLogic Pharmaceuticals CorporationOTCPK: TLOG | $2.43K | $— | — |
| OncoVista Innovative Therapies, Inc.OTCPK: OVIT | $2.36K | $— | — |
Figures last refreshed Oct 4, 2026.